Skip to main content
. 2010 Jan 5;25(3):220–227. doi: 10.1007/s11606-009-1204-5

Table 3.

Demographics of Study Participants

No. (%) of Participants
Primary care providers (n = 6) Liver specialists (n = 7) Other medical providers (n = 5) Total (n = 18)
Age, years
<30 0 0 2 (40) 2 (11)
30-39 0 1 (14) 1 (20) 2 (11)
40-49 2 (33) 3 (43) 0 5 (28)
50-65 3 (50) 2 (29) 1 (20) 6 (33)
>65 1 (17) 1 (14) 1 (20) 3 (17)
Gender
Male 5 (83) 6 (86) 3 (60) 14 (78)
Specialty
Gastroenterology/Hepatology 0 7 (100) 0 7 (38)
Internal medicine 3 (50) 0 0 3 (17)
Family practice 3 (50) 0 0 3 (17)
Obstetrics/Gynecology 0 0 1 (20) 1 (6)
Acupuncturist 0 0 2 (40) 2 (11)
Other 0 0 2 (40) 2 (11)
Completed US Residency?
Yes 6 (100) 6 (86) 3 (60) 15 (83)
Graduate of US medical school?
Yes 1 (17) 3 (43) 3 (60) 7 (39)
Ethnicity
Chinese 3 (50) 0 3 (60) 6 (33)
Korean 1 (17) 0 2 (40) 3 (17)
Vietnamese 2 (33) 1 (14) 0 3 (17)
Latino 0 1 (14) 0 1 (6)
Caucasian 0 3 (43) 0 3 (17)
Other 0 2 (29) 2 (11)
Native tongue
Chinese 3 (50) 0 0 3 (17)
Korean 1 (17) 0 2 (40) 3 (17)
Vietnamese 2 (33) 1 (14) 0 3 (17)
English 0 3 (43) 2 (40) 5 (28)
Other 0 3 (43) 1 (20) 4 (22)
% of patients who are Asian American
25% 2 (33) 4 (57) 4 (80) 10 (56)
25-50% 1 (17) 1 (14) 0 2 (11)
50-75% 2 (33) 0 1 (20) 3 (17)
>75% 1 (17) 1 (14) 0 2 (11)
No answer 0 1 (14) (0) 1 (6)
% of patients with insurance
0% 0 1 (14) 0 1 (6)
25% 5 (83) 4 (57) 3 (60) 12 (67)
25-50% 1 (17) 1 (14) 0 2 (11)
50-75% 0 0 2 (40) 2 (11)
>75% 0 1 (14) 0 1 (6)
Use translator as needed during visits with Asian American patients 4 (67) 6 (86) 2 (40) 12 (67)
HBV screening testsa
HBsAg 6 (100) 6 (86) 1 (20) 13 (72)
anti-HBe 4 (67) 2 (29) 2 (40) 8 (44)
anti-HBc 4 (67) 3 (43) 1 (20) 8 (44)
% of patients screened for HBV
25% 1 (17) 0 4 (80) 5 (28)
25-50% 2 (33) 1 (14) 0 3 (17)
50-75% 3 (50) 1 (14) 0 4 (22)
>75% 0 4 (57) 0 4 (22)
No answer 0 1 (14) 0 1 (6)

a HBsAg, hepatitis B surface antigen; anti-HBe, antibody to hepatitis B early antigen; anti-HBc, antibody to hepatitis B core antigen